Shields Health Solutions

One of the fastest growing companies in America, Shields Health Solutions partners with hospital leaders on every aspect of specialty pharmacy creation and growth. The company provides the fastest, lowest risk model for Hospital leaders to create and grow a hospital-owned specialty pharmacy business, whether starting from scratch or adding specialty capabilities to a hospital’s existing pharmacy programs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

INDUSTRIAL IMPACT

LINKINVAX AND INSERM TRANSFERT ENTER INTO AN EXCLUSIVE WORLDWIDE LICENSING AGREEMENT COVERING USE OF AN INNOVATIVE VACCINE PLATFORM

LinKinVax technology | February 04, 2022

news image

LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an innovative mechanism of action. LinKinVax is developing a vaccine platform that directly targets dendritic cells.These cells play a crucial role in the immune system, stimulating and regulating immune responses. The agreement with Inserm Transfert covers industrial and commercial use, and the...

Read More

MEDICAL

SOTIRA ANNOUNCES THE SUCCESSFUL COMPLETION OF SECOND PHASE OF PRE-CLINICAL TESTING FOR COVID-19 THERAPEUTIC AND VACCINE-ALTERNATIVE

Sotira | November 25, 2020

news image

Sotira, the Phoenix based biotech organization, is pleased to report the successful finish of the second period of pre-clinical testing for its COVID-19 therapeutic and vaccine-alternative, KEPTIDE™ COVID, confirming that this cutting-edge molecular therapy completely prevented of SARS-CoV2 in the lungs and kidney. These mice are viewed as a best quality level preclinical model to study COVID-19 on the grounds that the mice express human ACE2, the receptor utilized by the virus to gain ent...

Read More

RESEARCH

CEDILLA THERAPEUTICS EXPANDS LEADERSHIP TEAM WITH KEY APPOINTMENTS ACROSS R&D AND FINANCE

Cedilla Therapeutics | November 17, 2021

news image

Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, announced appointments across its research and development (R&D) and finance teams, including Joshua Murtie, Ph.D., as Vice President of Biology and Chris Lindblom as Vice President of Finance. These hires are part of an ongoing initiative to expand Cedilla’s leadership and enable future growth as the company progresses its lead programs, conditional inhibitors of TEAD and CDK2, toward the cli...

Read More

DIAGNOSTICS

MERIDIAN LAUNCHES NEW QPCR MASTER MIXES FOR STOOL SAMPLES TO ACCELERATE DEVELOPMENT OF MOLECULAR ASSAYS

Meridian | June 21, 2022

news image

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today two new sample-specific master mixes, Lyo-Ready™ Direct DNA qPCR Stool Mix, and Lyo-Ready™ Direct RNA/DNA qPCR Stool Mix. These innovative master mixes improve the molecular detection of DNA and RNA from crude fecal specimens while allowing room temperature stabilization of diagnostic assays. Stool samples are used in many ...

Read More
news image

INDUSTRIAL IMPACT

LINKINVAX AND INSERM TRANSFERT ENTER INTO AN EXCLUSIVE WORLDWIDE LICENSING AGREEMENT COVERING USE OF AN INNOVATIVE VACCINE PLATFORM

LinKinVax technology | February 04, 2022

LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an innovative mechanism of action. LinKinVax is developing a vaccine platform that directly targets dendritic cells.These cells play a crucial role in the immune system, stimulating and regulating immune responses. The agreement with Inserm Transfert covers industrial and commercial use, and the...

Read More
news image

MEDICAL

SOTIRA ANNOUNCES THE SUCCESSFUL COMPLETION OF SECOND PHASE OF PRE-CLINICAL TESTING FOR COVID-19 THERAPEUTIC AND VACCINE-ALTERNATIVE

Sotira | November 25, 2020

Sotira, the Phoenix based biotech organization, is pleased to report the successful finish of the second period of pre-clinical testing for its COVID-19 therapeutic and vaccine-alternative, KEPTIDE™ COVID, confirming that this cutting-edge molecular therapy completely prevented of SARS-CoV2 in the lungs and kidney. These mice are viewed as a best quality level preclinical model to study COVID-19 on the grounds that the mice express human ACE2, the receptor utilized by the virus to gain ent...

Read More
news image

RESEARCH

CEDILLA THERAPEUTICS EXPANDS LEADERSHIP TEAM WITH KEY APPOINTMENTS ACROSS R&D AND FINANCE

Cedilla Therapeutics | November 17, 2021

Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, announced appointments across its research and development (R&D) and finance teams, including Joshua Murtie, Ph.D., as Vice President of Biology and Chris Lindblom as Vice President of Finance. These hires are part of an ongoing initiative to expand Cedilla’s leadership and enable future growth as the company progresses its lead programs, conditional inhibitors of TEAD and CDK2, toward the cli...

Read More
news image

DIAGNOSTICS

MERIDIAN LAUNCHES NEW QPCR MASTER MIXES FOR STOOL SAMPLES TO ACCELERATE DEVELOPMENT OF MOLECULAR ASSAYS

Meridian | June 21, 2022

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today two new sample-specific master mixes, Lyo-Ready™ Direct DNA qPCR Stool Mix, and Lyo-Ready™ Direct RNA/DNA qPCR Stool Mix. These innovative master mixes improve the molecular detection of DNA and RNA from crude fecal specimens while allowing room temperature stabilization of diagnostic assays. Stool samples are used in many ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us